{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:50:08Z","timestamp":1771609808528,"version":"3.50.1"},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1961,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1111\/j.1365-2885.2010.01181.x","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T16:10:37Z","timestamp":1271693437000},"page":"573-582","source":"Crossref","is-referenced-by-count":16,"title":["Barazone decreases skin lesions and pruritus and increases quality of life in dogs with atopic dermatitis: a randomized, blinded, placebo-controlled trial"],"prefix":"10.1111","volume":"33","author":[{"given":"L. A.","family":"AHLSTROM","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. V.","family":"MASON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. C.","family":"MILLS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,19]]},"reference":[{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-3164.2000.00177.x","article-title":"Safety of long-term administration of a 0.01% fluocinolone shampoo in allergic dogs","volume":"11","author":"Beale","year":"2000","journal-title":"Veterinary Dermatology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00128071-200203010-00005","article-title":"New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use","volume":"3","author":"Brazzini","year":"2002","journal-title":"American Journal of Clinical Dermatology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0165-2427(01)00312-9","article-title":"The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis","volume":"81","author":"DeBoer","year":"2001","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0165-2427(01)00345-2","article-title":"The ACVD task force on canine atopic dermatitis (XII): the relationship of cutaneous infections to the pathogenesis and clinical course of canine atopic dermatitis","volume":"81","author":"DeBoer","year":"2001","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2460\/ajvr.2002.63.408","article-title":"Multiple-centre study of reduced-concentration triamcinolone topical solution for the treatment of dogs with known or suspected allergic pruritus","volume":"63","author":"DeBoer","year":"2002","journal-title":"American Journal of Veterinary Research"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-2427(01)00346-4","article-title":"The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations of canine atopic dermatitis","volume":"81","author":"Griffin","year":"2001","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB7|cit7","first-page":"223","volume-title":"Veterinary dermatopathology: a macroscopic and microscopic evaluation of canine and feline skin disease","author":"Gross","year":"1992"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB8|cit8","first-page":"275","volume-title":"Veterinary dermatopathology: a macroscopic and microscopic evaluation of canine and feline skin disease","author":"Gross","year":"1992"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-3164.1997.d01-3.x","article-title":"Subepidermal bullous dermatosis due to topical corticosteroid therapy in dogs","volume":"8","author":"Gross","year":"1997","journal-title":"Veterinary Dermatology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vetimm.2006.08.013","article-title":"Revised nomenclature for veterinary allergy","volume":"114","author":"Halliwell","year":"2006","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-2427(01)00309-9","article-title":"The ACVD task force on canine atopic dermatitis (III): the role of antibodies in canine atopic dermatitis","volume":"81","author":"Halliwell","year":"2001","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1017\/S0962728600031778","article-title":"Assessing quality of life in companion and kennelled dogs: a critical review","volume":"16","author":"Hewson","year":"2007","journal-title":"Animal Welfare"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-2427(01)00310-5","article-title":"The ACVD task force on canine atopic dermatitis (V): biology and role of inflammatory cells in cutaneous allergic reactions","volume":"81","author":"Hill","year":"2001","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-2427(01)00296-3","article-title":"The ACVD task force on canine atopic dermatitis (I): incidence and prevalence","volume":"81","author":"Hillier","year":"2001","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/019262339902700506","article-title":"Dorsal skin reactions of hairless dogs to topical treatment with corticosteroids","volume":"27","author":"Kimura","year":"1999","journal-title":"Toxicologic Pathology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB16|cit16","volume-title":"Duncan & Prasse\u2019s veterinary laboratory medicine: clinical pathology","author":"Latimer","year":"2003"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-2427(01)00300-2","article-title":"The ACVD task force on canine atopic dermatitis (VII): mediators of cutaneous inflammation","volume":"81","author":"Marsella","year":"2001","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0165-2427(01)00303-8","article-title":"The ACVD task force on canine atopic dermatitis (XIII): threshold phenomenon and summation of effects","volume":"81","author":"Marsella","year":"2001","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tvjl.2005.09.006","article-title":"Transdermal drug delivery: basic principles for the veterinarian","volume":"172","author":"Mills","year":"2006","journal-title":"Veterinary Journal"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB22|cit20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-3164.2009.00756.x","article-title":"Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomized, double blind, placebo-controlled trial","volume":"20","author":"Nuttall","year":"2009","journal-title":"Veterinary Dermatology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB24|cit21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-3164.2003.00335.x","article-title":"Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis","volume":"14","author":"Olivry","year":"2003","journal-title":"Veterinary Dermatology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB25|cit22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0165-2427(01)00347-6","article-title":"The ACVD task force on canine atopic dermatitis (XIX): general principles of therapy","volume":"81","author":"Olivry","year":"2001a","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB26|cit23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0165-2427(01)00314-2","article-title":"The ACVD task force on canine atopic dermatitis (XX): glucocorticoid pharmacotherapy","volume":"81","author":"Olivry","year":"2001b","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB28|cit24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-3164.2007.00569.x","article-title":"Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis","volume":"18","author":"Olivry","year":"2007","journal-title":"Veterinary Dermatology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB29|cit25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-3164.2007.00608.x","article-title":"Repeatability and reproducibility of numerical rating scales and visual analogue scales for canine pruritus severity scoring","volume":"18","author":"Plant","year":"2007","journal-title":"Veterinary Dermatology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB30|cit26","first-page":"1057","article-title":"Re-evaluation of diagnostic criteria of canine atopic dermatitis","volume":"149","author":"Prelaud","year":"1998","journal-title":"Revue De Medecine Veterinaire"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB32|cit27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1053\/j.ctsap.2006.05.003","article-title":"Practical applications of topical therapy for allergic, infectious, and seborrheic disorders","volume":"21","author":"Rosenkrantz","year":"2006","journal-title":"Clinical Techniques in Small Animal Practice"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB33|cit28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-3164.2008.00728.x","article-title":"Further validation of a pruritus severity scale for use in dogs","volume":"20","author":"Rybnicek","year":"2009","journal-title":"Veterinary Dermatology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB34|cit29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1365-2230.2000.00697.x","article-title":"Systemic therapy of atopic dermatitis","volume":"25","author":"Sidbury","year":"2000","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB35|cit30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-2427(01)00297-5","article-title":"The ACVD task force on canine atopic dermatitis (II): genetic factors","volume":"81","author":"Sousa","year":"2001","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB36|cit31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-3164.2005.00491.x","article-title":"A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs","volume":"17","author":"Steffan","year":"2006","journal-title":"Veterinary Dermatology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB37|cit32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-3164.1999.00146.x","article-title":"Effects of a 1% hydrocortisone conditioner on hematological and biochemical parameters, adrenal function testing and cutaneous reactivity to histamine in normal and pruritic dogs","volume":"10","author":"Thomas","year":"1999","journal-title":"Veterinary Dermatology"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB38|cit33","first-page":"74","article-title":"Atopic dermatitis in dogs: current diagnostic criteria","volume":"113","author":"Willemse","year":"1988","journal-title":"Tijdschrift voor Diergeneeskunde"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB39|cit34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2460\/javma.1987.191.06.685","article-title":"Adrenocortical suppression by topically applied corticosteroids in healthy dogs","volume":"191","author":"Zenoble","year":"1987","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1111\/j.1365-2885.2010.01181.x-BIB40|cit35","first-page":"273","volume-title":"Current Veterinary Dermatology: The Science and Art of Therapy","author":"Zerbe","year":"1993"}],"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2885.2010.01181.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2885.2010.01181.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:19:03Z","timestamp":1740017943000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2885.2010.01181.x"}},"subtitle":["Barazone treatment for canine atopic dermatitis"],"short-title":[],"issued":{"date-parts":[[2010,4,19]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2885.2010.01181.x","relation":{},"ISSN":["0140-7783"],"issn-type":[{"value":"0140-7783","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4,19]]}}}